# Effectiveness of Hydroxychloroquine in Covid-19 Patients

> **NCT04328272** · PHASE3 · UNKNOWN · sponsor: **Prof. Dr. Umar Farooq** · enrollment: 75 (estimated)

## Conditions studied

- COVID19

## Interventions

- **DRUG:** Hydroxychloroquine 200 Mg Oral Tablet
- **DRUG:** Azithromycin 500Mg Oral Tablet
- **DIETARY_SUPPLEMENT:** Glucose tablets

## Key facts

- **NCT ID:** NCT04328272
- **Lead sponsor:** Prof. Dr. Umar Farooq
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-28
- **Primary completion:** 2020-05-28
- **Final completion:** 2020-06-28
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2020-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328272, "Effectiveness of Hydroxychloroquine in Covid-19 Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04328272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*